TITLE:
Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

CONDITION:
Carcinoma, Non-small-cell Lung

INTERVENTION:
TLK286

SUMMARY:

      The purpose of this study is to determine the effectiveness of TLK286 in the treatment of
      advanced non-small cell lung cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Histologic or cytologic diagnosis of non-small cell lung carcinoma

          -  Progressed while on or after treatment on platinum-based regimen

          -  Patients may not have had more than one prior cytotoxic chemotherapy regimen

          -  Stage IV or IIIB

          -  Age at least 18 years

          -  Adequate liver and kidney function

          -  Adequate bone marrow function

        Exclusion Criteria:

          -  Pregnancy or lactation

          -  Unstable medical conditions

          -  Chemotherapy, hormonal therapy, radiotherapy, radiopharmaceuticals or immunotherapy
             within 3 weeks of TLK286

          -  CNS metastasis unless controlled by treatment
      
